Diseases, Conditions, Syndromes

High sustained response rate for glecaprevir, pibrentasvir in HCV

(HealthDay)—For patients with stage 4 or 5 chronic kidney disease and hepatitis C virus (HCV) infection, 12 weeks of treatment with glecaprevir and pibrentasvir results in a high rate of sustained virologic response, according ...

Diseases, Conditions, Syndromes

State laws can promote hepatitis C virus screening

(HealthDay)—Mandating health care providers to offer hepatitis C virus (HCV) screening can increase screening rates and linkage to care among those with newly diagnosed infection, according to research published in the ...

Health

VA models provide guidance for care of hepatitis C infection

(HealthDay)—The U.S. Department of Veterans Affairs (VA) has developed models of care that can be used to reduce the overall burden of hepatitis C virus (HCV) infection, according to a study published online Sept. 25 in ...

Diseases, Conditions, Syndromes

Non-specialists can expand hepatitis C treatment access

(HealthDay)—Non-specialists, including primary care providers (PCPs) and nurse practitioners (NPs), safely and effectively administer direct-acting antiviral therapy for hepatitis C virus (HCV) to patients seen in federally ...

Diseases, Conditions, Syndromes

EHR-based prompt ups hepatitis C screening for baby boomers

(HealthDay)—Implementation of an electronic health record (EHR)-based prompt can improve hepatitis C virus (HCV) screening rates among baby boomers, according to a study published online July 17 in Hepatology.

Diabetes

Improved glycemic control with eradication of hepatitis C

(HealthDay)—For patients with type 2 diabetes, direct-acting antiviral (DAA) treatment of hepatitis C virus (HCV) is associated with improved glycemic control and reduced antidiabetic medication use, according to a study ...

page 6 from 15